The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors

Immunity

Volumn 41, Issue 3, 2014, Pages 389-401

  Thevenot, Paul T ^a   Sierra, Rosa A ^a   Raber, Patrick L ^a   Al Khami, Amir A ^a   Trillo Tinoco, Jimena ^a   Zarreii, Parisa ^a   Ochoa, Augusto C ^a   Cui, Yan ^a   DelValle, Luis ^a   Rodriguez, Paulo C ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; INTERLEUKIN 6; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; ATF4 PROTEIN, MOUSE; DDIT3 PROTEIN, MOUSE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CELL FUNCTION; CELL STRESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PROTEIN EXPRESSION; SENSOR; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR IMMUNITY; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL PROLIFERATION; ENDOTHELIUM CELL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); TUMOR CELL LINE; TUMOR ESCAPE;

ACTIVATING TRANSCRIPTION FACTOR 4; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANSCRIPTION FACTOR CHOP; TUMOR ESCAPE;

EID: 84908003234     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.08.015     Document Type: Article

References (47)

1. Avivar-Valderas A., Salas E., Bobrovnikova-Marjon E., Diehl J.A., Nagi C., Debnath J., Aguirre-Ghiso J.A. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol. Cell. Biol. 2011, 31:3616-3629.
2. Bi M., Naczki C., Koritzinsky M., Fels D., Blais J., Hu N., Harding H., Novoa I., Varia M., Raleigh J., et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 2005, 24:3470-3481.
3. Bobrovnikova-Marjon E., Grigoriadou C., Pytel D., Zhang F., Ye J., Koumenis C., Cavener D., Diehl J.A. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene 2010, 29:3881-3895.
4. Bronte V., Kasic T., Gri G., Gallana K., Borsellino G., Marigo I., Battistini L., Iafrate M., Prayer-Galetti T., Pagano F., Viola A. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J.Exp. Med. 2005, 201:1257-1268.
5. Chen D.S., Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity 2013, 39:1-10.
6. Chitnis N.S., Pytel D., Bobrovnikova-Marjon E., Pant D., Zheng H., Maas N.L., Frederick B., Kushner J.A., Chodosh L.A., Koumenis C., et al. miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner. Mol. Cell 2012, 48:353-364.
7. Condamine T., Kumar V., Ramachandran I.R., Youn J.I., Celis E., Finnberg N., El-Deiry W.S., Winograd R., Vonderheide R.H., English N.R., et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J.Clin. Invest. 2014, 124:2626-2639.
8. Corzo C.A., Cotter M.J., Cheng P., Cheng F., Kusmartsev S., Sotomayor E., Padhya T., McCaffrey T.V., McCaffrey J.C., Gabrilovich D.I. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J.Immunol. 2009, 182:5693-5701.
9. Coussens L.M., Zitvogel L., Palucka A.K. Neutralizing tumor-promoting chronic inflammation: a magic bullet?. Science 2013, 339:286-291.
10. Dalton L.E., Clarke H.J., Knight J., Lawson M.H., Wason J., Lomas D.A., Howat W.J., Rintoul R.C., Rassl D.M., Marciniak S.J. The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma. Br. J. Cancer 2013, 108:1340-1347.
11. De Santo C., Serafini P., Marigo I., Dolcetti L., Bolla M., Del Soldato P., Melani C., Guiducci C., Colombo M.P., Iezzi M., et al. Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc. Natl. Acad. Sci. USA 2005, 102:4185-4190.
12. Descombes P., Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991, 67:569-579.
13. DeZwaan-McCabe D., Riordan J.D., Arensdorf A.M., Icardi M.S., Dupuy A.J., Rutkowski D.T. The stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesis. PLoS Genet. 2013, 9:e1003937.
14. Dolcetti L., Peranzoni E., Bronte V. Measurement of myeloid cell immune suppressive activity. Curr. Protoc. Immunol. 2010, 14. Unit 14.17.
15. Endo M., Mori M., Akira S., Gotoh T. C/EBP homologous protein (CHOP) is crucial for the induction of caspase-11 and the pathogenesis of lipopolysaccharide-induced inflammation. J.Immunol. 2006, 176:6245-6253.
16. Esposito V., Grosjean F., Tan J., Huang L., Zhu L., Chen J., Xiong H., Striker G.E., Zheng F. CHOP deficiency results in elevated lipopolysaccharide-induced inflammation and kidney injury. Am. J. Physiol. Renal Physiol. 2013, 304:F440-F450.
17. Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012, 12:253-268.
18. Grant R.W., Nguyen K.Y., Ravussin A., Albarado D., Youm Y.H., Dixit V.D. Inactivation of C/ebp homologous protein driven immune-metabolic interactions exacerbate obesity and adipose tissue leukocytosis. J.Biol. Chem. 2014, 289:14045-14055.
19. Harding H.P., Zhang Y., Zeng H., Novoa I., Lu P.D., Calfon M., Sadri N., Yun C., Popko B., Paules R., et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 2003, 11:619-633.
20. Hart L.S., Cunningham J.T., Datta T., Dey S., Tameire F., Lehman S.L., Qiu B., Zhang H., Cerniglia G., Bi M., et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J.Clin. Invest. 2012, 122:4621-4634.
21. Hattori T., Ohoka N., Hayashi H., Onozaki K. C/EBP homologous protein (CHOP) up-regulates IL-6 transcription by trapping negative regulating NF-IL6 isoform. FEBS Lett. 2003, 541:33-39.
22. Huber A.L., Lebeau J., Guillaumot P., Pétrilli V., Malek M., Chilloux J., Fauvet F., Payen L., Kfoury A., Renno T., et al. p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose. Mol. Cell 2013, 49:1049-1059.
23. Kim K.M., Yu T.K., Chu H.H., Park H.S., Jang K.Y., Moon W.S., Kang M.J., Lee D.G., Kim M.H., Lee J.H., Chung M.J. Expression of ER stress and autophagy-related molecules in human non-small cell lung cancer and premalignant lesions. Int. J. Cancer 2012, 131:E362-E370.
24. Liu H., Huang L., Bradley J., Liu K., Bardhan K., Ron D., Mellor A.L., Munn D.H., McGaha T.L. GCN2 dependent metabolic stress is essential for cytokine induction and pathology in murine sepsis. Mol. Cell. Biol. 2014, 34:428-438.
25. Loinard C., Zouggari Y., Rueda P., Ramkhelawon B., Cochain C., Vilar J., Récalde A., Richart A., Charue D., Duriez M., et al. C/EBP homologous protein-10 (CHOP-10) limits postnatal neovascularization through control of endothelial nitric oxide synthase gene expression. Circulation 2012, 125:1014-1026.
26. Lu T., Ramakrishnan R., Altiok S., Youn J.I., Cheng P., Celis E., Pisarev V., Sherman S., Sporn M.B., Gabrilovich D. Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic Tcells in mice. J.Clin. Invest. 2011, 121:4015-4029.
27. Mahadevan N.R., Rodvold J., Sepulveda H., Rossi S., Drew A.F., Zanetti M. Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells. Proc. Natl. Acad. Sci. USA 2011, 108:6561-6566.
28. Malhi H., Kaufman R.J. Endoplasmic reticulum stress in liver disease. J.Hepatol. 2011, 54:795-809.
29. Malhi H., Kropp E.M., Clavo V.F., Kobrossi C.R., Han J., Mauer A.S., Yong J., Kaufman R.J. C/EBP homologous protein-induced macrophage apoptosis protects mice from steatohepatitis. J.Biol. Chem. 2013, 288:18624-18642.
30. Marigo I., Bosio E., Solito S., Mesa C., Fernandez A., Dolcetti L., Ugel S., Sonda N., Bicciato S., Falisi E., et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010, 32:790-802.
31. Movahedi K., Guilliams M., Van den Bossche J., Van den Bergh R., Gysemans C., Beschin A., De Baetselier P., Van Ginderachter J.A. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct Tcell-suppressive activity. Blood 2008, 111:4233-4244.
32. Mundy-Bosse B.L., Lesinski G.B., Jaime-Ramirez A.C., Benninger K., Khan M., Kuppusamy P., Guenterberg K., Kondadasula S.V., Chaudhury A.R., La Perle K.M., et al. Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res. 2011, 71:5101-5110.
33. Munn D.H., Sharma M.D., Baban B., Harding H.P., Zhang Y., Ron D., Mellor A.L. GCN2 kinase in Tcells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 2005, 22:633-642.
34. Namba T., Tanaka K., Ito Y., Ishihara T., Hoshino T., Gotoh T., Endo M., Sato K., Mizushima T. Positive role of CCAAT/enhancer-binding protein homologous protein, a transcription factor involved in the endoplasmic reticulum stress response in the development of colitis. Am. J. Pathol. 2009, 174:1786-1798.
35. Pearce E.L., Poffenberger M.C., Chang C.H., Jones R.G. Fueling immunity: insights into metabolism and lymphocyte function. Science 2013, 342:1242454.
36. Raber P., Ochoa A.C., Rodríguez P.C. Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of Tcell suppression and therapeutic perspectives. Immunol. Invest. 2012, 41:614-634.
37. Rouschop K.M., van den Beucken T., Dubois L., Niessen H., Bussink J., Savelkouls K., Keulers T., Mujcic H., Landuyt W., Voncken J.W., et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J.Clin. Invest. 2010, 120:127-141.
38. Rzymski T., Harris A.L. The unfolded protein response and integrated stress response to anoxia. Clin. Cancer Res. 2007, 13:2537-2540.
39. Sawant A., Schafer C.C., Jin T.H., Zmijewski J., Tse H.M., Roth J., Sun Z., Siegal G.P., Thannickal V.J., Grant S.C., et al. Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways. Cancer Res. 2013, 73:6609-6620.
40. Scaiewicz V., Nahmias A., Chung R.T., Mueller T., Tirosh B., Shibolet O. CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model. PLoS ONE 2013, 8:e81065.
41. Schafer Z.T., Brugge J.S. IL-6 involvement in epithelial cancers. J.Clin. Invest. 2007, 117:3660-3663.
42. Schönthal A.H. Pharmacological targeting of endoplasmic reticulum stress signaling in cancer. Biochem. Pharmacol. 2013, 85:653-666.
43. Sonda N., Chioda M., Zilio S., Simonato F., Bronte V. Transcription factors in myeloid-derived suppressor cell recruitment and function. Curr. Opin. Immunol. 2011, 23:279-285.
44. Sonda N., Simonato F., Peranzoni E., Calì B., Bortoluzzi S., Bisognin A., Wang E., Marincola F.M., Naldini L., Gentner B., et al. miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis. Immunity 2013, 38:1236-1249.
45. Talmadge J.E., Gabrilovich D.I. History of myeloid-derived suppressor cells. Nat. Rev. Cancer 2013, 13:739-752.
46. Vasquez-Dunddel D., Pan F., Zeng Q., Gorbounov M., Albesiano E., Fu J., Blosser R.L., Tam A.J., Bruno T., Zhang H., et al. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J.Clin. Invest. 2013, 123:1580-1589.
47. Ye J., Kumanova M., Hart L.S., Sloane K., Zhang H., De Panis D.N., Bobrovnikova-Marjon E., Diehl J.A., Ron D., Koumenis C. The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J. 2010, 29:2082-2096.